Millennium Management LLC trimmed its position in shares of LifeVantage Corp (NASDAQ:LFVN) by 11.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 98,305 shares of the company’s stock after selling 13,029 shares during the period. Millennium Management LLC’s holdings in LifeVantage were worth $355,000 at the end of the most recent quarter.

Separately, Dimensional Fund Advisors LP boosted its stake in LifeVantage by 14.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 128,172 shares of the company’s stock valued at $463,000 after purchasing an additional 15,857 shares during the period. 16.20% of the stock is owned by institutional investors.

Separately, ValuEngine raised shares of LifeVantage from a “hold” rating to a “buy” rating in a research note on Wednesday, June 13th.

LifeVantage stock opened at $11.54 on Friday. The company has a quick ratio of 0.91, a current ratio of 1.53 and a debt-to-equity ratio of 0.21. The stock has a market cap of $160.99 million, a price-to-earnings ratio of 42.89 and a beta of 0.75. LifeVantage Corp has a 52-week low of $2.86 and a 52-week high of $12.19.

LifeVantage Company Profile

LifeVantage Corporation identifies, researches, develops, and distributes nutraceutical dietary supplements and skin care products. It offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to combat oxidative stress in dogs.

Featured Article: Understanding Price to Earnings Ratio (PE)

Want to see what other hedge funds are holding LFVN? Visit to get the latest 13F filings and insider trades for LifeVantage Corp (NASDAQ:LFVN).

Institutional Ownership by Quarter for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with's FREE daily email newsletter.